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In pooled analyses, where covariates may not be uniformly defined and coded across 
studies, and occasionally not measured in all of them, a joint model is often not feasible, and 
a two-stage method (see [1] for instance) is a simple, valid and practical method for the 
analysis, lending itself to flexibility with respect to differences in design, confounders and 
data collection across studies and to a better control for confounding. Simulations indicate 
that when the individual studies are large, two-stage methods produce nearly unbiased 
exposure estimates and standard errors of the exposure estimates from a generalized linear 
mixed model (GLMM). 
Based on these considerations, several existing cancer epidemiology consortia suggested in 
their protocols to apply two-stage methods instead of fitting GLMMs directly on the overall 
sample (see [2] for instance), although they still struggle to harmonize exposure variables of 
interest and potential confounders. However, it is unclear how well the two-stage method 
would perform if individual studies were smaller, especially when there are a few of them [3]. 
This may be a critical issue, especially as far as evidence has been accumulating on the 
major research questions a consortium was born for, and time is mature for more specific 
analyses on subgroups of studies. 
The International Head and Neck Cancer Epidemiology (INHANCE) consortium was 
established in 2004 to contribute elucidating the aetiology of head and neck cancer by 
providing opportunities for pooled analyses of individual-level data on a large scale. In the 
current version, the consortium included 35 case-control studies, with questionnaire data on 
over 26,000 cases and 34,000 controls [4]. Only 10 studies in the consortium provided 
detailed information on nutrient intakes. The available studies differ in terms of number of 
subjects included, geographical region, assessment of dietary information and food 
composition tables. 
This naturally provides a real-life situation of interest to understand how big is the difference, 
if any, in the effect estimates derived from the two-stage methods and the GLMM. In detail, 
we discuss this point in an application on vitamin C intake and head and neck cancer, after 
a preprocessing step improving comparability across studies. 
This research question may have important fallouts in the refinement of the statistical 
methods supporting the recent global effort towards pooling individual-level data in 
consortia. 
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